Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Complement metabolism in rheumatoid arthritis. I. Longitudinal studies.

× No keyword cloud information.

26 in total

1. Presence of aggregated gamma-G-globulin in certain rheumatoid synovial effusions.

Authors: K Hannestad
Journal: Clin Exp Immunol Date: 1967-07 Impact factor: 4.330

2. Intracytoplasmic inclusions of immunoglobulins in rheumatoid arthritis and other diseases.

Authors: J H Vaughan; E V Barrnett; M V Sobel; R F Jacox
Journal: Arthritis Rheum Date: 1968-04

Review 3. Complement in human disease.

Authors: P H Schur; K F Austen
Journal: Annu Rev Med Date: 1968 Impact factor: 13.739

4. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors: D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal: Q J Med Date: 1968-07

5. Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors: P H Schur; J Sandson
Journal: N Engl J Med Date: 1968-03-07 Impact factor: 91.245

6. Quantitative immunoelectrophoresis of human serum proteins.

Authors: H G Clarke; T Freeman
Journal: Clin Sci Date: 1968-10 Impact factor: 6.124

7. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors: C B Laurell
Journal: Anal Biochem Date: 1966-04 Impact factor: 3.365

8. Serum complement levels in rheumatoid arthritis. A longitudinal study of 43 cases with correlation of clinical and serological data including rheumatoid factor and thermolabile inhibitor of the F-II L.P. test.

Authors: A F Schubart; R W Ewald; W C Schroeder; H J Rothschild; D N Bhatavadekar; P K Pullen
Journal: Ann Rheum Dis Date: 1965-09 Impact factor: 19.103

9. In vivo metabolism of complement. I. Metabolism of the third component (C'3) in acquired hemolytic anemia.

Authors: L D Petz; D J Fink; E A Letsky; H H Fudenberg; J Müller-Eberhard
Journal: J Clin Invest Date: 1969-11 Impact factor: 14.808

10. Alper CA, Rosen FS: Studies of the in vivo behavior of human C'3 in normal subjects and patients.

Authors: C A Alper; F S Rosen
Journal: J Clin Invest Date: 1967-12 Impact factor: 14.808

16 in total

1. Proceedings: Raised levels of complement inactivation products in ankylosing spondylitis.

Authors: R D Sturrock; A J Barret; J Versey; P Rennolds
Journal: Ann Rheum Dis Date: 1975-04 Impact factor: 19.103

2. Studies of the action of some anti-inflammatory drugs on complement mediated immune haemolysis.

Authors: K Whaley; D J Sloane
Journal: Br J Clin Pharmacol Date: 1975-04 Impact factor: 4.335

3. Complement metabolism in the seronegative arthritides.

Authors: K Whaley; B Canesi; A Moseley; W Morrow; R Sturrock; W Mitchell; W C Dick
Journal: Ann Rheum Dis Date: 1974-11 Impact factor: 19.103

4. Examination of complement C3 metabolism in rheumatoid arthritis using 2-dimensional immunoelectrophoresis.

Authors: M F Shadforth; D C McNaughton
Journal: Ann Rheum Dis Date: 1978-02 Impact factor: 19.103

Review 5. Immune complexes in human diseases: a review.

Authors: A N Theofilopoulos; F J Dixon
Journal: Am J Pathol Date: 1980-08 Impact factor: 4.307

6. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.

Authors: P Davis; R H Cumming; J Verrier-Jones
Journal: Clin Exp Immunol Date: 1977-05 Impact factor: 4.330

Review 7. Activation of complement in relation to disease.

Authors: J M Versey; L Slater; J R Hobbs
Journal: J Clin Pathol Suppl (Assoc Clin Pathol) Date: 1975

8. Complement and immunoglobulins in synovial fluid from synovectomized patients with rheumatoid arthritis.

Authors: O J Mellbye; B Naes; E Munthe
Journal: Ann Rheum Dis Date: 1976-06 Impact factor: 19.103

9. Determination of the half-life of C3 in patients and its relation to the presence of C3-breakdown products and/or circulating immune complexes.

Authors: A J Swaak; A Hannema; C Vogelaar; F A Boom; L van Es; R van Aalst; L W Statius van Eps
Journal: Rheumatol Int Date: 1982 Impact factor: 2.631

10. Correlation in rheumatoid arthritis of concentrations of plasma C3d, serum rheumatoid factor, immune complexes and C-reactive protein with each other and with clinical features of disease activity.

Authors: R K Mallya; D Vergani; D E Tee; L Bevis; F C de Beer; H Berry; E D Hamilton; B E Mace; M B Pepys
Journal: Clin Exp Immunol Date: 1982-06 Impact factor: 4.330